These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 14264744)
1. VARIABILITY OF THE ANTICOAGULANT FRACTION OF INCUBATED FIBRINOGEN. TRIANTAPHYLLOPOULOS E; TRIANTAPHYLLOPOULOS DC Am J Physiol; 1965 Mar; 208():521-7. PubMed ID: 14264744 [No Abstract] [Full Text] [Related]
2. THERMOSTABLE ANTICOAGULANT FROM THE ANTICOAGULANT FRACTION OF INCUBATED FIBRINOGEN. TRIANTAPHYLLOPOULOS E; TRIANTAPHYLLOPOULOS DC Br J Haematol; 1965 May; 11():331-41. PubMed ID: 14282070 [No Abstract] [Full Text] [Related]
3. INFLUENCE OF FIBRINOGEN DEGRADATION PRODUCTS (FDP) ON PLATELET AGGREGATION, ADHESIVENESS AND VISCOUS METAMORPHOSIS. KOWALSKI E; KOPEC M; WEGRZYNOWICZ Z Thromb Diath Haemorrh; 1964 Jan; 10():406-23. PubMed ID: 14113380 [No Abstract] [Full Text] [Related]
4. MECHANISM OF HUMAN PLASMINOGEN ACTIVATION BY STREPTOKINASE AND HUMAN PLASMIN. BLATT WF; GRAY JL; JENSEN H Thromb Diath Haemorrh; 1964 Apr; 11():85-93. PubMed ID: 14167118 [No Abstract] [Full Text] [Related]
5. THE FORMATION OF CHONDROMUCOPROTEIN-FIBRINOGEN AND CHONDROMUCOPROTEIN-BETA-LIPOPROTEIN COMPLEXES. ANDERSON AJ Biochem J; 1963 Sep; 88(3):460-9. PubMed ID: 14071519 [No Abstract] [Full Text] [Related]
6. FRACTIONATION AND STANDARDIZATION OF PLASMA FIBRINOLYTIC COMPONENTS. MACKAY M Br Med Bull; 1964 Sep; 20():189-94. PubMed ID: 14209757 [No Abstract] [Full Text] [Related]
7. THE INACTIVATION OF STREPTOKINASE BY TAME. ROBERTS PS Can J Biochem; 1964 Dec; 42():1841-4. PubMed ID: 14241619 [No Abstract] [Full Text] [Related]
8. [FIBRINOLYSIS INHIBITORS AND DETERMINATION OF PHYSIOLOGICAL AND PATHOLOGICAL ANTIPLASMIN ACTIVITY]. MORIAU M; DE VRIES SI; DIK HJ Thromb Diath Haemorrh; 1964 Jan; 10():355-78. PubMed ID: 14113376 [No Abstract] [Full Text] [Related]
9. STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS. KOWALSKI E; BUDZYNSKI AZ; KOPEC M; LATALLO ZS; LIPINSKI B; WEGRZYNOWICZ Z Thromb Diath Haemorrh; 1964 Oct; 12():69-86. PubMed ID: 14224647 [No Abstract] [Full Text] [Related]
10. INACTIVATION OF STREPTOKINASE BY BOVINE PLASMIN. GODAL HC; HELLE I Scand J Clin Lab Invest; 1963; 15():529-32. PubMed ID: 14086328 [No Abstract] [Full Text] [Related]
11. A METHOD FOR DETECTING AND ESTIMATING PLASMINOGEN IN CEREBROSPINAL FLUID. NEWMAN RL J Clin Pathol; 1964 May; 17(3):313-5. PubMed ID: 14159469 [No Abstract] [Full Text] [Related]
12. ACTION OF THE NEW ANTI-FIBRINOLYTIC SUBSTANCE ON THE STREPTOKINASE-ACTIVATED PROTEASES (PLASMINS). MIHARA H Kobe J Med Sci; 1963 Dec; 18():169-77. PubMed ID: 14160537 [No Abstract] [Full Text] [Related]
13. ISOLATION AND PROPERTIES OF ANTICOAGULANTS FROM FIBRINOLYSED AND HUMAN HEART-PUMP PLASMAS. TRIANTAPHYLLOPOULOS DC; TRIANTAPHYLLOPOULOS E Can J Physiol Pharmacol; 1964 Mar; 42():169-87. PubMed ID: 14329312 [No Abstract] [Full Text] [Related]
14. FIBRINOGEN BREAKDOWN PRODUCTS. LEWIS JH; WILSON JH Am J Physiol; 1964 Nov; 207():1053-7. PubMed ID: 14237449 [No Abstract] [Full Text] [Related]
15. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON BLOOD COAGULATION IN DOGS. LEWIS JH; SHIRAKAWA M Am J Physiol; 1964 Nov; 207():1049-52. PubMed ID: 14237448 [No Abstract] [Full Text] [Related]
16. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS]. MATTIOLI G; RABITTI G; NAVA C Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219 [No Abstract] [Full Text] [Related]
17. THE LABORATORY CONTROL OF THROMBOLYTIC THERAPY. HAWKEY C; HOWELL M J Clin Pathol; 1964 May; 17(3):287-91. PubMed ID: 14159462 [TBL] [Abstract][Full Text] [Related]